- call +1-201-465-4211
- email sales@mrinsights.biz
Age-related macular degeneration (AMD) is a disease that blurs the sharp, central vision you need for “straight-ahead” activities such as reading, sewing, and driving. AMD affects the macula, the part of the eye that allows you to see fine detail.
Scope of the Report:
Age Related Macular Degeneration Drug is widely used in hospitals, clinics and other field. The most proportion of Age Related Macular Degeneration Drug is used in Hospital, and the proportion in 2017 is 72%.
North America is the largest consumption place, with a consumption market share nearly 65.6% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 30%.
The worldwide market for Age Related Macular Degeneration Drug is expected to grow at a CAGR of roughly 6.1% over the next five years, will reach 8670 million US$ in 2024, from 6080 million US$ in 2019, according to a new study.
This report focuses on the Age Related Macular Degeneration Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Regeneron Pharmaceuticals
Bayer HealthCare
Novartis
Roche
Kanghong Pharma
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Lucentis
Eylea
Avastin
Other
Market Segment by Applications, can be divided into
Hospitals
Clinics
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Age Related Macular Degeneration Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Age Related Macular Degeneration Drug, with price, sales, revenue and global market share of Age Related Macular Degeneration Drug in 2017 and 2018.
Chapter 3, the Age Related Macular Degeneration Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Age Related Macular Degeneration Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Age Related Macular Degeneration Drug market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Age Related Macular Degeneration Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Age Related Macular Degeneration Drug Introduction
1.2 Market Analysis by Type
1.2.1 Lucentis
1.2.2 Eylea
1.2.3 Avastin
1.2.4 Other
1.3 Market Analysis by Applications
1.3.1 Hospitals
1.3.2 Clinics
1.3.3 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Regeneron Pharmaceuticals
2.1.1 Business Overview
2.1.2 Age Related Macular Degeneration Drug Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Bayer HealthCare
2.2.1 Business Overview
2.2.2 Age Related Macular Degeneration Drug Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Bayer HealthCare Age Related Macular Degeneration Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Novartis
2.3.1 Business Overview
2.3.2 Age Related Macular Degeneration Drug Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Novartis Age Related Macular Degeneration Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Roche
2.4.1 Business Overview
2.4.2 Age Related Macular Degeneration Drug Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Roche Age Related Macular Degeneration Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Kanghong Pharma
2.5.1 Business Overview
2.5.2 Age Related Macular Degeneration Drug Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Kanghong Pharma Age Related Macular Degeneration Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Age Related Macular Degeneration Drug Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Age Related Macular Degeneration Drug Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Age Related Macular Degeneration Drug Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Age Related Macular Degeneration Drug Manufacturer Market Share in 2018
3.3.2 Top 6 Age Related Macular Degeneration Drug Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Age Related Macular Degeneration Drug Market Analysis by Regions
4.1 Global Age Related Macular Degeneration Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Age Related Macular Degeneration Drug Sales and Market Share by Regions (2014-2019)
4.1.2 Global Age Related Macular Degeneration Drug Revenue and Market Share by Regions (2014-2019)
4.2 North America Age Related Macular Degeneration Drug Sales and Growth Rate (2014-2019)
4.3 Europe Age Related Macular Degeneration Drug Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Age Related Macular Degeneration Drug Sales and Growth Rate (2014-2019)
4.5 South America Age Related Macular Degeneration Drug Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Age Related Macular Degeneration Drug Sales and Growth Rate (2014-2019)
5 North America Age Related Macular Degeneration Drug by Country
5.1 North America Age Related Macular Degeneration Drug Sales, Revenue and Market Share by Country
5.1.1 North America Age Related Macular Degeneration Drug Sales and Market Share by Country (2014-2019)
5.1.2 North America Age Related Macular Degeneration Drug Revenue and Market Share by Country (2014-2019)
5.2 United States Age Related Macular Degeneration Drug Sales and Growth Rate (2014-2019)
5.3 Canada Age Related Macular Degeneration Drug Sales and Growth Rate (2014-2019)
5.4 Mexico Age Related Macular Degeneration Drug Sales and Growth Rate (2014-2019)
6 Europe Age Related Macular Degeneration Drug by Country
6.1 Europe Age Related Macular Degeneration Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Age Related Macular Degeneration Drug Sales and Market Share by Country (2014-2019)
6.1.2 Europe Age Related Macular Degeneration Drug Revenue and Market Share by Country (2014-2019)
6.2 Germany Age Related Macular Degeneration Drug Sales and Growth Rate (2014-2019)
6.3 UK Age Related Macular Degeneration Drug Sales and Growth Rate (2014-2019)
6.4 France Age Related Macular Degeneration Drug Sales and Growth Rate (2014-2019)
6.5 Russia Age Related Macular Degeneration Drug Sales and Growth Rate (2014-2019)
6.6 Italy Age Related Macular Degeneration Drug Sales and Growth Rate (2014-2019)
7 Asia-Pacific Age Related Macular Degeneration Drug by Country
7.1 Asia-Pacific Age Related Macular Degeneration Drug Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Age Related Macular Degeneration Drug Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Age Related Macular Degeneration Drug Revenue and Market Share by Country (2014-2019)
7.2 China Age Related Macular Degeneration Drug Sales and Growth Rate (2014-2019)
7.3 Japan Age Related Macular Degeneration Drug Sales and Growth Rate (2014-2019)
7.4 Korea Age Related Macular Degeneration Drug Sales and Growth Rate (2014-2019)
7.5 India Age Related Macular Degeneration Drug Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Age Related Macular Degeneration Drug Sales and Growth Rate (2014-2019)
8 South America Age Related Macular Degeneration Drug by Country
8.1 South America Age Related Macular Degeneration Drug Sales, Revenue and Market Share by Country
8.1.1 South America Age Related Macular Degeneration Drug Sales and Market Share by Country (2014-2019)
8.1.2 South America Age Related Macular Degeneration Drug Revenue and Market Share by Country (2014-2019)
8.2 Brazil Age Related Macular Degeneration Drug Sales and Growth Rate (2014-2019)
8.3 Argentina Age Related Macular Degeneration Drug Sales and Growth Rate (2014-2019)
8.4 Colombia Age Related Macular Degeneration Drug Sales and Growth Rate (2014-2019)
9 Middle East and Africa Age Related Macular Degeneration Drug by Countries
9.1 Middle East and Africa Age Related Macular Degeneration Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Age Related Macular Degeneration Drug Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Age Related Macular Degeneration Drug Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Age Related Macular Degeneration Drug Sales and Growth Rate (2014-2019)
9.3 Turkey Age Related Macular Degeneration Drug Sales and Growth Rate (2014-2019)
9.4 Egypt Age Related Macular Degeneration Drug Sales and Growth Rate (2014-2019)
9.5 Nigeria Age Related Macular Degeneration Drug Sales and Growth Rate (2014-2019)
9.6 South Africa Age Related Macular Degeneration Drug Sales and Growth Rate (2014-2019)
10 Global Age Related Macular Degeneration Drug Market Segment by Type
10.1 Global Age Related Macular Degeneration Drug Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Age Related Macular Degeneration Drug Sales and Market Share by Type (2014-2019)
10.1.2 Global Age Related Macular Degeneration Drug Revenue and Market Share by Type (2014-2019)
10.2 Lucentis Sales Growth and Price
10.2.1 Global Lucentis Sales Growth (2014-2019)
10.2.2 Global Lucentis Price (2014-2019)
10.3 Eylea Sales Growth and Price
10.3.1 Global Eylea Sales Growth (2014-2019)
10.3.2 Global Eylea Price (2014-2019)
10.4 Avastin Sales Growth and Price
10.4.1 Global Avastin Sales Growth (2014-2019)
10.4.2 Global Avastin Price (2014-2019)
10.5 Other Sales Growth and Price
10.5.1 Global Other Sales Growth (2014-2019)
10.5.2 Global Other Price (2014-2019)
11 Global Age Related Macular Degeneration Drug Market Segment by Application
11.1 Global Age Related Macular Degeneration Drug Sales Market Share by Application (2014-2019)
11.2 Hospitals Sales Growth (2014-2019)
11.3 Clinics Sales Growth (2014-2019)
11.4 Other Sales Growth (2014-2019)
12 Age Related Macular Degeneration Drug Market Forecast (2019-2024)
12.1 Global Age Related Macular Degeneration Drug Sales, Revenue and Growth Rate (2019-2024)
12.2 Age Related Macular Degeneration Drug Market Forecast by Regions (2019-2024)
12.2.1 North America Age Related Macular Degeneration Drug Market Forecast (2019-2024)
12.2.2 Europe Age Related Macular Degeneration Drug Market Forecast (2019-2024)
12.2.3 Asia-Pacific Age Related Macular Degeneration Drug Market Forecast (2019-2024)
12.2.4 South America Age Related Macular Degeneration Drug Market Forecast (2019-2024)
12.2.5 Middle East and Africa Age Related Macular Degeneration Drug Market Forecast (2019-2024)
12.3 Age Related Macular Degeneration Drug Market Forecast by Type (2019-2024)
12.3.1 Global Age Related Macular Degeneration Drug Sales Forecast by Type (2019-2024)
12.3.2 Global Age Related Macular Degeneration Drug Market Share Forecast by Type (2019-2024)
12.4 Age Related Macular Degeneration Drug Market Forecast by Application (2019-2024)
12.4.1 Global Age Related Macular Degeneration Drug Sales Forecast by Application (2019-2024)
12.4.2 Global Age Related Macular Degeneration Drug Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Age Related Macular Degeneration Drug Picture
Table Product Specifications of Age Related Macular Degeneration Drug
Figure Global Sales Market Share of Age Related M
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
